Correlation Between 25-Hydroxy-Vitamin D [25(Oh) D] Levels And Polycystic Ovary Syndrome In Obese Women: A Case-Control Study
Keywords:
Vitamin D, obesity, polycystic ovary syndromeAbstract
Background: Polycystic ovary syndrome (PCOS) occurs around 38-88% in overweight or obese women. Obese women with PCOS tend to have lower serum vitamin D levels compared to lean women with PCOS.
Objective: This study aimed to analyze the relationship between 25-hydroxy-vitamin D [25(OH)D] levels in obese women with PCOS.
Methods: This case-control study was conducted on 80 obese women aged between 26-35 yrs old from January to December 2024 at Hasanuddin University hospital and Wahidin Sudirohusodo hospital, Makassar, Indonesia. All participants were divided into 2 groups: women with PCOS (n=40) and women without PCOS (n=40).
All women were measured for body mass index (BMI) and Serum 25(OH)D levels were measured using enzyme-linked immunosorbent assay ELISA.
Results: This study found that obese women with PCOS had 25(OH)D levels that were significantly lower than obese women without PCOS (p value=0.004). However, women with PCOS tend to have a higher BMI than women without PCOS (p value=0.052). Low 25(OH)D levels are weak correlation with increased BMI (r=-0.265, p value=0.017).
Conclusion: Vitamin D levels were low in obese women with PCOS, therefore vitamin D supplementation in PCOS may be recommended.
Downloads
References
Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: A review of treatment options with a focus on pharmacological approaches. P T. 2013;38(6):336–55.
Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. J Endocr Soc. 2019;3(8):1545–73. doi:10.1210/js.2019-00078.
Aly YE, Abdou AS, Rashad MM, Nassef MM. Effect of exercise on serum vitamin D and tissue vitamin D receptors in experimentally induced type 2 Diabetes Mellitus. J Adv Res. 2016;7(5):671–9. doi:10.1016/j.jare.2016.07.001.
Grundmann M, von Versen-Höynck F. Vitamin D - roles in women’s reproductive health? Reprod Biol Endocrinol. 2011;9(1):146. doi:10.1186/1477-7827-9-146.
Pal L. Polycystic ovarian syndrome. New York: Springer; 2013. doi:10.1007/978-1-4614-8394-6_19.
Ibrahim ZM, Ahmed Kishk E, Mohamed Fahmy S, Tharwat Taha O. Serum 1,25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome. Obstet Gynecol Reports. 2020;4(1):1–3. doi:10.15761/ogr.1000141.
Sidabutar E, Halim B, Siregar MFG, Lutan D, Adenin I, Kaban Y. Vitamin D Levels in Women with Polycystic Ovary Syndrome. ASPIRE Conf Proc. 2016. doi:10.18502/kme.v1i1.547
Lakshman L, Pillai B, Lakshman R, Kumar H, Sudha S, Jayakumar R. Comparison of vitamin D levels in obese and non-obese patients with polycystic ovarian syndrome in a South Indian population. Int J Reprod Contraception, Obstet Gynecol. 2013;2(3):336–43. doi:10.5455/2320-1770.ijrcog20130915.
Ni Z, Mei S, You S, Lin Y, Cheng W, Zhou L, et al. Adverse Effects of Polycystic Ovarian Syndrome on Pregnancy Outcomes in Women With Frozen-Thawed Embryo Transfer: Propensity Score-Matched Study. Front Endocrinol (Lausanne). 2022;13:878853. doi:10.3389/fendo.2022.878853.
Talmo MSA, Fløysand IS, Nilsen GØ, Løvvik TS, Ødegård R, Juliusson PB, et al. Growth Restriction in the Offspring of Mothers With Polycystic Ovary Syndrome. JAMA Netw Open. 2024;7(8):e2430543. doi:10.1001/jamanetworkopen.2024.30543.
Collée J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol. 2021;37(10):869–74. doi:10.1080/09513590.2021.1958310.
Cunha A, Póvoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomed J. 2021;6(1):e116. doi:10.1097/j.pbj.0000000000000116.
Kicińska AM, Maksym RB, Zabielska-Kaczorowska MA, Stachowska A, Babińska A. Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome. Biomedicines. 2023;11(6):1567. doi:10.3390/biomedicines11061567.
Fang Y, Liu L, Yang Y, Zhang B, Xie S. Causal Association Between BMI and Polycystic Ovarian Syndrome: Bidirectional 2-Sample Mendelian Randomization Study. J Clin Endocrinol Metab. 2024. doi:10.1210/clinem/dgae446
Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian J Endocrinol Metab. 2016;20(3):324–8. doi:10.4103/2230-8210.180005.
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, et al. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022;23(2):583. doi:10.3390/ijms23020583.
Pateguana NB, Janes A. The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome. J Metab Health. 2019;4(1):50. doi:10.4102/jir.v4i1.50.
Mogili KD, Karuppusami R, Thomas S, Chandy A, Kamath MS, TK A. Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome – A prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2018;229:15–9. doi:10.1016/j.ejogrb.2018.08.001
Cahyo H, Yuad H, Rahmah BI. The relationship of vitamin D to polycystic ovary syndrome (PCOS) teenagers at Koto Tangah Padang District High School in 2022. Andalas Obstet Gynecol J. 2018;4(4):527–34. doi:10.25077/aoj.8.1.615-631.2024
Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77(3):343–50. doi:10.1111/j.1365-2265.2012.04434.x.
Suhartono J, Astiarani Y, Regina. Association between body mass index and vitamin D serum in Asian population: a systematic review. Public Health Prev Med Arch. 2022;10(1):69–79. doi:10.53638/phpma.2022.v10.i1.p08.
Gokosmanoglu F, Onmez A, Ergenç H. The relationship between vitamin D deficiency and polycystic ovary syndrome. Afr Health Sci. 2020;20(4):1880–6. doi:10.4314/ahs.v20i4.45.
Anjum S, Saleem A, Noor S, Mahmood A, Khalid S, Sarwa A. Relationship of vitamin D deficiency with obesity, metabolic abnormalities and insulin resistance in patients with PCOS. Pak J Med Health Sci. 2022;16(7):115–7. doi:10.53350/pjmhs22167115.
Fattah A, Al-Kader DA, Jones Amaowei EE, Amini H, Hewadmal H, Rasuli SF, et al. A comparative study of luteinizing hormone levels in polycystic ovarian syndrome with hyperandrogenism: Metformin versus oral contraceptive pills. Cureus. 2022;14(9):e29487. doi:10.7759/cureus.29487.
Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front Nutr. 2023; doi:10.3389/fnut.2023.1070808.
Octavius GS, Daleni VA, Angeline G, Virliani C. A systematic review and meta-analysis of prevalence of vitamin D deficiency among Indonesian pregnant women: A public health emergency. AJOG Glob Rep. 2023;3(2):100189. doi:10.1016/j.xagr.2023.100189.
Sukarsa RA, Budi RS, Purwara BH, Syam HH, Sadikin H. Differences of vitamin D level in non-pregnant reproductive age women and first trimester pregnant women. Indones J Obstet Gynecol. 2019;7(4):2–7. doi:10.32771/inajog.v7i4.998
Herlambang, Safira NNA, Fitri AD, Puspasari A. Gambaran kadar vitamin D pada wanita usia subur: model kebijakan kesehatan reproduksi. Medic. 2021;4(1):269–73. doi:10.22437/medicaldedication.v4i2.15597
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 28 Tahun 2019 tentang Angka Kecukupan Gizi yang Dianjurkan untuk Masyarakat Indonesia. Sustain. 2019;11(1):1–14. https://peraturan.bpk.go.id/Details/138621/permenkes-no-28-tahun-2019
Mohan A, Haider R, Fakhor H, Hina F, Kumar V, Jawed A, et al. Vitamin D and polycystic ovary syndrome (PCOS): a review. Ann Med Surg. 2023;85:3506–11. doi:10.1097/ms9.0000000000000879
Alloubani A, Akhu-Zaheya L, Samara R, Abdulhafiz I, Saleh A, Altowijri A. Relationship between vitamin D deficiency, diabetes, and obesity. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):1457–61. doi:10.1016/j.dsx.2019.02.021.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
